The North America fertility market size was estimated at USD 13.76 billion in 2025 and is projected to be worth around USD 31.11 billion by 2035, growing at a CAGR of 8.5% from 2026 to 2035. Advanced healthcare structure and increasing infertility rates are driving the market.

North America Fertility Market Statical Scope

North America is currently experiencing significant growth in the fertility market. This region benefits from an advanced healthcare infrastructure, substantial disposable incomes, and a growing awareness of fertility treatments. Regulatory support, exemplified by the Affordable Care Act, has further facilitated market growth by mandating insurance coverage for fertility treatments in numerous states.

The demand for assisted reproductive technologies (ART) is on the rise, influenced by evolving societal norms and trends toward delayed parenthood. Notably, infertility rates in North America are increasing due to lifestyle factors including obesity, stress, smoking, and environmental influences, coupled with a cultural shift towards prioritizing education and career advancement before starting families. This has resulted in an escalating demand for technologies such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg freezing across the United States and Canada.

North America Fertility Market Share, By Country, 2025

• Canada- A growing number of Canadians are struggling with fertility , and the business helping people make babies is booming, which is boosting the fertility market in Canada.

North America Fertility Market Share, By Offering, 2025, (%)

• Assisted Reproductive Technology (ART)- Advanced fertility treatments such as IVF and egg/sperm donation. Dominates with 72% share due to its vital role in overcoming infertility challenges and widespread use in fertility treatments.
• Fertility drugs- Pharmaceutical solutions to stimulate ovulation and treat infertility hold 28% share due to ART's higher success rates and broader usage in fertility treatments.

North America Fertility Market Share, By End User, 2025, (%)

• Fertility clinics- Specialized clinics providing a range of reproductive services, including ART, dominate with 65% share due to the growing demand for specialized, accessible, and efficient fertility treatments.
• Hospitals- Larger healthcare institutions providing fertility services account for 25% share due to the specialized nature of fertility treatments requiring more dedicated facilities.
• Clinical research institutes- Institutions focused on fertility research and innovation hold 10% share due to a smaller role in the actual provision of fertility treatments, which focus on advancing reproductive medicine through trials.

Top Companies in the North America Fertility Market

• Fertility Market Companies
• Boston IVF Fertility Clinic
• INVO Bioscience
• San Diego Fertility Center
• Celmatix
• FUJIFILM IRVINE SCIENTIFIC
• Carolinas Fertility Institute
• Progyny Inc.
• Cook Medical

Segments Covered in the Report

By Offering

• Assisted Reproductive Technology
  
  • IVF
  • Artificial Insemination
  • Surrogacy
  • Others
• Fertility Drugs
  
  • Gonadotropin
  • Anti-estrogen
  • Others

By End user

• Fertility Clinics
• Hospitals
• Clinical Research Institutes